SearchDictionaryMobileLogin

[Use of angiotensin-converting enzyme inhibitors in chronic kidney insufficiency]

AbstractAIM: To study effects of ACE inhibitors in patients with diffuse renal diseases at the stage of chronic renal failure (CRF). MATERIAL AND METHODS: Acute changes in renal filtration and in renal hemodynamics in response to 100-200 mg captopril were studied in 7 patients with CRF and 6 patients with intact renal function. Effects of long-term ACE inhibitors were retrospectively studied in 50 patients with CRF (27 men, 23 women, mean age 46.0 +/- 1.9 years, 7 patients were over 60 years old). Sixteen patients were selected from this group who were followed up for a long time. They were examined for CRF progression rate when given conventional antihypertensive treatment and after treatment with ACE inhibitors. RESULTS: Acute response to ACE inhibitors was the following: SCF fell by 18.4% on the average by the end on therapy week 1; by the end of week 3 renal hemodynamics showed stability, SCF returned to normal, effective renal plasm flow rose by 16.9%, serum potassium rose significantly after 7 days of treatment but did not reach 6 mmol/l. Effects of long-term ACE inhibitor in CRF: the treatment was discontinued after 30-60 days in 12 of 50 patients because of high creatinine (> 20%); in 38 patients ACE inhibitor had a pronounced antihypertensive and antiproteinuric action for 2-3 years, creatinine growth inhibited. Progression of CRF became slow. CONCLUSION: ACE-inhibitors in CRF had a nephroprotective effect but blood creatinine levels should be controlled especially within the first 1-2 months of treatment.
AuthorsI M Kutyrina, N L Lifshits, V A Rogov, E S Kamyshova, M Iu Shvetsov, E B Okonova, S O Androsova, S A Martynov, N G Miroshnichenko, O I Gerasimenko
JournalTerapevticheskiĭ arkhiv (Ter Arkh) Vol. 74 Issue 6 Pg. 34-9 ( 2002) ISSN: 0040-3660 Russia
Vernacular TitlePrimenenie ingibitorov angiotenzinprevrashchaiushchego fermenta pri khronicheskoĭ pochechnoĭ nedostatochnosti.
PMID12136480 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • Creatinine
  • Captopril
  • Potassium
Topics
  • Adult
  • Angiotensin-Converting Enzyme Inhibitors (adverse effects, therapeutic use)
  • Captopril (adverse effects, therapeutic use)
  • Creatinine (blood)
  • Female
  • Glomerular Filtration Rate
  • Hemodynamics
  • Humans
  • Kidney Failure, Chronic (drug therapy, physiopathology)
  • Male
  • Middle Aged
  • Potassium (blood)